MAPT and Alzheimer disease: These include amyloid-beta (Aβ), pathologic tau, and markers indicating neurodegeneration, such as total tau (t-tau) and neurofilament light chain (NFL), which play important roles in the diagnosis, treatment, and prognosis of AD [5–7].